Form D · Biotechnology
ALUNG TECHNOLOGIES INC
Pittsburgh, PA · CIK 0001179295
Offering snapshot reported Aug 24, 2021 · SEC filing
- Reported sold
- $4.59M Offering amount: $12M
- Investors reported
- Not reported Form D · investor count
- Minimum accepted
- Not reported Reported outside-investor minimum
- First sale
- Not reported As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Aug 24, 2021 | Amendment | $4,589,862 | No comparison | Not reported | SEC filing |
| May 18, 2021 | Initial | $1,810,537 | No comparison | 7 | SEC filing |
| Nov 12, 2020 | Initial | $5,441,577 | No comparison | 47 | SEC filing |
| Jun 1, 2020 | Initial | $2,000,000 | No comparison | 1 | SEC filing |
| Feb 27, 2020 | Amendment | $3,262,900 | $8,547vs Jan 29, 2020 | 52 | SEC filing |
| Feb 21, 2020 | Initial | $3,000,000 | No comparison | 1 | SEC filing |
| Jan 29, 2020 | Initial | $3,254,353 | No comparison | 51 | SEC filing |
| Aug 14, 2019 | Initial | $5,000,000 | No comparison | 48 | SEC filing |
| Jan 8, 2019 | Initial | $4,999,990 | No comparison | 61 | SEC filing |
| Dec 12, 2017 | Amendment | $37,544,283 | $128,391vs Aug 2, 2017 | 96 | SEC filing |
| Aug 2, 2017 | Amendment | $37,415,892 | $859,380vs Apr 13, 2017 | 95 | SEC filing |
| Apr 13, 2017 | Initial | $36,556,512 | No comparison | 93 | SEC filing |
| Feb 16, 2017 | Amendment | $2,602,233 | $43,744vs Jan 10, 2017 | 37 | SEC filing |
| Jan 10, 2017 | Initial | $2,558,489 | No comparison | 36 | SEC filing |
| Feb 19, 2016 | Amendment | $12,000,000 | $1,163,186vs Jan 13, 2016 | 79 | SEC filing |
| Jan 13, 2016 | Amendment | $10,836,814 | $305,017vs Dec 4, 2015 | 63 | SEC filing |
| Dec 4, 2015 | Amendment | $10,531,797 | $6,781,797vs May 18, 2015 | 57 | SEC filing |
| May 18, 2015 | Amendment | $3,750,000 | $0vs May 12, 2015 | 31 | SEC filing |
| May 12, 2015 | Initial | $3,750,000 | No comparison | 31 | SEC filing |
| Jul 15, 2014 | Amendment | $10,843,753 | $1,381,134vs Apr 15, 2014 | 109 | SEC filing |
| May 28, 2014 | Amendment | $10,012,619 | $550,000vs Apr 15, 2014 | 69 | SEC filing |
| Apr 15, 2014 | Initial | $9,462,619 | No comparison | 67 | SEC filing |
| Sep 13, 2013 | Amendment | $15,785,268 | $1,045,505vs Jul 18, 2013 | 55 | SEC filing |
| Jul 18, 2013 | Amendment | $14,739,763 | $5,256,999vs Jun 20, 2013 | 48 | SEC filing |
| Jun 20, 2013 | Amendment | $9,482,764 | $2,273,296vs Apr 10, 2013 | 42 | SEC filing |
| Apr 10, 2013 | Initial | $7,209,468 | No comparison | 33 | SEC filing |
| Feb 8, 2012 | Amendment | $10,000,000 | $1,187,719vs Dec 19, 2011 | 42 | SEC filing |
| Dec 19, 2011 | Amendment | $8,812,281 | $2,201,878vs Nov 28, 2011 | 40 | SEC filing |
| Nov 28, 2011 | Initial | $6,610,403 | No comparison | 36 | SEC filing |
| Oct 22, 2010 | Amendment | $13,500,000 | $7,379,181vs Apr 21, 2010 | 62 | SEC filing |
| Apr 21, 2010 | Amendment | $6,120,819 | $2,830,507vs Feb 18, 2010 | 22 | SEC filing |
| Feb 18, 2010 | Initial | $3,290,312 | No comparison | 12 | SEC filing |
| Oct 2, 2009 | Initial | $2,581,340 | No comparison | 18 | SEC filing |
| Jul 18, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Apr 12, 2006 | Paper | Not reported | No comparison | Not reported | |
| Dec 23, 2005 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Oct 5, 2005 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Not reported
- Exemptions
- Not reported
- Duration over one year
- Not reported
- Business combination
- Not reported
- Sales commissions
- Not reported
- Finders' fees
- Not reported
- Form D file number
- 021-399770
Source: Form D, filed Aug 24, 2021. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Louis Choy | Director |
| Nicholas E. Cullen | Director |
| Jeanne Cunicelli | Director |
| Jeanne Cunnicelli | Director |
| Peter M. De Como | Director, Executive |
| Gary G. Glausser | Director |
| David J. Haffner | Executive |
| Nicholas J. Kuhn | Director, Executive |
| John Kuzmishin | Director |
| Kraig J. Mc Ewen | Director |
| Gerald E. Mc Ginnis | Director |
| John Mc Illwraith | Director |
| John E. Mc Ilwraith | Director |
| David Motley | Director |
| William B. Ross | Director |
| Adam G. Seiver | Director |
| Joseph J Stevens | Director |
| Joseph J. Stevens Iii | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
2500 Jane Street Suite 1
Pittsburgh, PA, 15203
Pittsburgh, PA, 15203